Shank3 expression is reduced in aged and AD human brains along with a general trend of synaptic loss, which might be related to impaired glutamatergic neurotransmission, cerebral hypometabolism, and cognitive deficits. This evidence concerns the gene SHANK3 and Alzheimer disease.